Olaparib Keeps Hereditary Breast Tumors in Check [News in Brief]

For metastatic breast cancer with BRCA mutations, PARP inhibitor beats chemo in phase III trial for the first time.

from Cancer via ola Kala on Inoreader http://ift.tt/2sy0tNd
via IFTTT